Intravenous (Iv) Solutions Market Analysis Asia, North America, Europe, Rest of World (ROW) - US, Germany, China, UK, Canada - Size and Forecast 2024-2028

Intravenous Solutions Market Size 2024-2028

The intravenous solutions market size is estimated to grow by USD 4.96 billion at a CAGR of 8.09% between 2023 and 2028. The healthcare industry is witnessing a significant shift towards specialized nutritional therapies, particularly in the areas of parenteral nutrition. Fueled by the increasing prevalence of chronic diseases and a growing geriatric population, the demand for clinical nutrition is on the rise. Parenteral nutrition is a medical intervention that delivers essential nutrients directly into the bloodstream through a vein, bypassing the gastrointestinal tract. This therapy is often used for individuals who cannot absorb nutrients through the gastrointestinal tract due to conditions such as gastrointestinal tract disorders, malabsorption, or severe injury. With advancements in technology and increasing awareness of the benefits of proper nutrition in chronic disease management, parenteral nutrition is becoming an essential component of modern healthcare.

What will be the Size of the Intravenous Solutions Market During the Forecast Period?

To learn more about this intravenous solutions market report, Request Free Sample

Intravenous Solutions Market Dynamics

The market is witnessing significant growth due to the increasing prevalence of various diseases, especially among the geriatric population. IV Solutions, also known as intravenous fluids, are essential medical products used to provide essential nutrients, water, electrolytes, sugar, and other essential elements directly into the bloodstream. The rising incidence of diseases such as malnutrition, gastrointestinal disorders, neurological conditions, infection, and cancer is driving the demand for IV Solutions. Moreover, the high prevalence of low immunity levels and cardiovascular disorders, especially in the elderly, is also fueling the market growth. The market for IV Solutions includes various types of products such as Water, Electrolytes, Sugar, Vitamin C supplements, and Parenteral nutrition products. The market is witnessing significant growth, driven by advancements in intravenous (IV) therapy and vein access techniques. The increasing demand for infusion therapy devices has propelled the market, as these devices are essential for administering IV treatments effectively. Additionally, the development of innovative intravenous (IV) fluid monitoring devices enhances patient care by ensuring accurate and timely delivery of fluids.

The market also benefits from the widespread use of intravenous (IV) fluid bags, which provide a convenient and sterile solution for fluid administration. Overall, these advancements are shaping the future of the market, catering to the growing healthcare needs. The worldwide cancer incidence is also a significant factor contributing to the growth of the market, particularly for colorectal cancer patients undergoing IV therapy during treatment. The market is segmented by application areas such as Intensive care, Postoperative treatment, and Spinal injuries. The increasing number of preterm births and the growing number of intensive care patients are also expected to boost the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Drivers

The increasing prevalence of chronic diseases is notably driving the market growth. The market is growing rapidly due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. IV solutions are used to treat a variety of medical conditions and are critical for delivering fluids, electrolytes, and medications to patients. According to the International Diabetes Federation (IDF), the number of people with diabetes is expected to reach 700 million by 2045. Diabetic patients require intravenous solutions for glucose control, and the increasing prevalence of diabetes is expected to increase the demand for intravenous solutions during the forecast period.

In addition, the increasing number of cancer cases is also boosting the growth of the market. Cancer patients often require intravenous solutions to manage chemotherapy side effects such as dehydration and electrolyte imbalance. According to the American Cancer Society, the number of cancer cases worldwide is expected to reach 28.4 million by 2040, which should further increase the demand for IV solutions. Hence, the increasing prevalence of chronic diseases is expected to boost the growth of the market during the forecast period.  

Significant Market Trends

Technological advancements in IV solutions are a key trend influencing the Market growth. IV solutions are used to deliver medicines, fluids, and nutrients directly into the bloodstream and are an important part of modern medical practice. The latest technological advancements in IV solutions have improved their efficiency, safety, and effectiveness, thereby driving the market. One of the recent technological advances in the  market is the development of intelligent IV pumps. Intelligent IV pumps are designed to improve patient safety and reduce the risk of medication errors by automatically adjusting infusion rates based on patient weight, age, and medical condition. 

Another technological advancement in the market is the development of closed system transfer devices (CSTDs). CSTDs are designed to protect healthcare workers from exposure to dangerous drugs during the preparation and administration of intravenous therapy. CSTDs are becoming increasingly important in cancer therapy, where dangerous drugs are frequently used. Moreover, the use of nanotechnology in IV solutions is another technological breakthrough driving the market globally. Nanotechnology is being used to develop infusion solutions that deliver drugs and nutrients to the body more effectively and efficiently. Technological advances in IV solutions are expected to drive the growth of the market by improving the safety, efficacy, and efficiency of IV therapies. Hence, such factors are driving the market during the forecast period.

Major Market Challenges

The high cost of IV solutions is challenging the Market growth. The cost of IV solutions continues to increase and this trend is expected to continue during the forecast period. This cost increase is due to several factors, such as the high cost of raw materials, manufacturing processes, and transportation costs.  The high cost of IV solutions hinders the global market in several ways. First, demand for IV solutions is declining as many healthcare providers and patients cannot afford IV solutions due to their high cost. This is especially true in developing countries where access to affordable healthcare is already limited. Furthermore, the high cost of IV solutions has led to lower profitability for IV solution manufacturers and distributors. This is because many healthcare providers are switching to cheaper alternatives such as oral medications and subcutaneous injections to cut costs.

Many cancer patients require IV solutions as part of their treatment, but the high cost of these solutions can place a financial burden on both patients and healthcare providers. Therefore, the high cost of IV solutions is a major challenge for the Market during the forecast period.  

Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Who are the Major Intravenous Solutions Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Amanta Healthcare Ltd: The company offers a wide range of IV solutions, including rehydration solutions such as sodium chloride, dextrose, and pre-mixed solutions such as sodium chloride injection, in pack sizes from 100mL to 500mL. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

• Axa Parenterals Ltd.
• Baxter International Inc.
• Fresenius SE and Co. KGaA
• Grifols SA
• ICU Medical Inc.
• JW Pharmaceutical Corp.
• Lxir Medilabs Pvt. Ltd.
• MITS Healthcare Pvt. Ltd.
• Pfizer Inc.
• Salius Pharma Pvt. Ltd.
• Schwitz Biotech
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Soxa Formulations and Research Pvt. Ltd.
• Terumo Group
• Vifor Pharma Management Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Intravenous Solutions Market?

The market share growth by the partial parenteral nutrition segment will be significant during the forecast period. Partial parenteral nutrition (PPN) is a type of IV therapy that provides partial nutritional support to patients who cannot obtain adequate oral nutrition. It is used when the patient's gastrointestinal tract is partially functioning, but oral intake is not sufficient to meet the body's needs. PPN solutions typically contain combinations of glucose, electrolytes, and amino acids in varying ratios based on the patient's specific needs. For example, patients with liver disease may require solutions with low concentrations of amino acids, and patients with renal failure may require solutions with high concentrations of electrolytes. 

Get a glance at the market contribution of various segments View the PDF Sample

The partial parenteral nutrition segment was valued at USD 3.96 billion in 2018. Partial parenteral nutrition (PPN) is often used in combination with enteral nutrition (EN). With EN, nutrients are delivered directly to the gastrointestinal tract via a feeding tube. The use of both PPN and EN is called dual nutritional support and is common in critically ill patients. PPN is a type of IV solution used to provide partial nutritional support to patients who cannot obtain adequate nutrients orally. Hence, this segment will contribute to the growth of the market during the forecast period. 

Which are the Key Regions for the Market?

For more insights on the market share of various regions Download PDF Sample now!

Asia is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Asia is projected to be the largest market in 2023 and the forecast period, with Japan, China, Singapore, India, and South Korea being the largest contributors in terms of revenue. The market is driven by rising healthcare costs, the rising prevalence of chronic diseases, and an aging population. The growing focus of key market players on emerging markets, increasing disposable income, the introduction of infusion therapy devices, and the increasing number of clinics and hospitals such as Fortis Healthcare (India) and Singapore General Hospital (Singapore) are also contributing to market growth. In addition, the increasing prevalence of chronic diseases such as cancer and the increasing geriatric population whose patients need to receive essential nutritional products via intravenous route will drive the growth of the market during the forecast period. 

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Type Outlook
  • Partial parenteral nutrition
  • Total parenteral nutrition

• Distribution Channel Outlook
  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Middle East
    • South Africa

Market Analyst Overview

Intravenous (IV) solutions have become an essential component of healthcare, particularly for managing various diseases and conditions in both adults and babies. The increasing geriatric population, with their unique healthcare needs, is a significant driver for the market. Malnutrition, preterm births, Neurological diseases and neurological conditions are some of the diseases where IV solutions play a crucial role. These solutions provide essential hydration, medications, and nutrients, maintaining electrolyte balance in the bloodstream. IV solutions cater to various age groups, including pediatric, adult, and geriatric patients. Neonatal patients, especially those with chronic diseases, require specialized IV solutions, including single-disease amino acids and parenteral lipid emulsions. IV catheters and infusion pumps are essential devices for administering these solutions. The composition of IV solutions varies, including carbohydrates, proteins, fats, vitamins, and minerals. IV solutions are used to treat dehydration, infections, and critical illnesses. Healthcare expenditure and infrastructure growth, along with increasing patient awareness, fuel the market's growth. The market is vast and diverse, catering to various diseases and patient populations, making it an integral part of the global healthcare landscape.

View the PDF sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch